Cost-effectiveness of prophylactic antibiotic use to prevent catheter-associated urinary tract infections

被引:4
作者
Wang, Rui [1 ]
Hacker, Michele R. [1 ,2 ,3 ]
Lefevre, Roger [1 ,2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Obstet, Gynecology, 330 Brookline Ave, Kirstein 3, Boston, MA 02215 USA
[2] Harvard Med Sch, Dept Obstet, Gynecology, Reprod Biol, Boston, MA 02115 USA
[3] Chan Sch Publ Hlth, Dept Epidmiol, Harvard T, Boston, MA 02115 USA
关键词
Costs and cost analysis; Cost-benefit analysis; Antibiotic prophylaxis; Urinary tract infections; Catheter-related infections;
D O I
10.1007/s00192-019-04034-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose We evaluate the cost-effectiveness of prophylactic antibiotic use to prevent catheter-associated urinary tract infections. Materials and methods A decision tree model was used to assess the cost-effectiveness of prophylactic antibiotics in preventing catheter-associated urinary tract infections for patients with a short-term indwelling urinary catheter. The model accounted for incidence of urinary tract infections with and without the use of prophylactic antibiotics, incidence of antibiotic-resistant urinary tract infections, as well as costs associated with diagnosis and treatment of urinary tract infections and antibiotic-resistant urinary tract infections. Costs were calculated from the health care system's perspective. We conducted one-way sensitivity analyses. Results The base case analysis showed that the use of prophylactic antibiotics is cost-saving in preventing catheter-associated urinary tract infections. The use of prophylactic antibiotics resulted in lower costs and higher quality-adjusted life-years compared with no prophylactic antibiotics. Sensitivity analyses showed that the optimal strategy changes to no prophylactic antibiotics when the incidence of urinary tract infections after prophylactic antibiotics exceeds 22% or the incidence of developing urinary tract infections without prophylactic antibiotics is less than 12%. Varying the costs of prophylactic antibiotics, urinary tract infection treatment, or antibiotic-resistant urinary tract infection treatment within a reasonable range did not change the optimal strategy. Conclusions Prophylactic antibiotic use to prevent catheter-associated urinary tract infections is cost-effective under most conditions. These results were sensitive to the likelihood of developing catheter-associated urinary tract infections with and without prophylactic antibiotics. Our results are limited to the cost-effectiveness perspective on this clinical practice.
引用
收藏
页码:285 / 289
页数:5
相关论文
共 15 条
[1]  
Barry HC, 1997, J FAM PRACTICE, V44, P49
[2]   Intermittent self catheterisation with hydrophilic, gel reservoir, and non-coated catheters: a systematic review and cost effectiveness analysis [J].
Bermingham, Sarah L. ;
Hodgkinson, Sarah ;
Wright, Sue ;
Hayter, Ellie ;
Spinks, Julian ;
Pellowe, Carol .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
[3]   AN EVALUATION OF DAILY BACTERIOLOGIC MONITORING TO IDENTIFY PREVENTABLE EPISODES OF CATHETER-ASSOCIATED URINARY-TRACT INFECTION [J].
GARIBALDI, RA ;
MOONEY, BR ;
EPSTEIN, BJ ;
BRITT, MR .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1982, 3 (06) :466-470
[4]   CATHETER-ASSOCIATED URINARY-TRACT INFECTIONS IN SURGICAL PATIENTS - A CONTROLLED-STUDY ON THE EXCESS MORBIDITY AND COSTS [J].
GIVENS, CD ;
WENZEL, RP .
JOURNAL OF UROLOGY, 1980, 124 (05) :646-648
[5]   The Economic Effect of Screening Orthopedic Surgery Patients Preoperatively for Methicillin-Resistant Staphylococcus aureus [J].
Lee, Bruce Y. ;
Wiringa, Ann E. ;
Bailey, Rachel R. ;
Goyal, Vishal ;
Tsui, Becky ;
Lewis, G. Jonathan ;
Muder, Robert R. ;
Harrison, Lee M. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (11) :1130-1138
[6]   Universal Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance for Adults at Hospital Admission: An Economic Model and Analysis [J].
Lee, Bruce Y. ;
Bailey, Rachel R. ;
Smith, Kenneth J. ;
Muder, Robert R. ;
Strotmeyer, Elsa S. ;
Lewis, G. Jonathan ;
Ufberg, Paul J. ;
Song, Yeohan ;
Harrison, Lee H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (06) :598-606
[7]   Staphylococcus aureus vaccine for orthopedic patients: An economic model and analysis [J].
Lee, Bruce Y. ;
Wiringa, Ann E. ;
Bailey, Rachel R. ;
Lewis, G. Jonathan ;
Feura, Jared ;
Muder, Robert R. .
VACCINE, 2010, 28 (12) :2465-2471
[8]   Antibiotic prophylaxis for short-term catheter bladder drainage in adults [J].
Lusardi, Gail ;
Lipp, Allyson ;
Shaw, Christine .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (07)
[9]   Multistate Point- Prevalence Survey of Health Care- Associated Infections [J].
Magill, Shelley S. ;
Edwards, Jonathan R. ;
Bamberg, Wendy ;
Beldavs, Zintars G. ;
Dumyati, Ghinwa ;
Kainer, Marion A. ;
Lynfield, Ruth ;
Maloney, Meghan ;
McAllister-Hollod, Laura ;
Nadle, Joelle ;
Ray, Susan M. ;
Thompson, Deborah L. ;
Wilson, Lucy E. ;
Fridkin, Scott K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (13) :1198-1208
[10]   Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis [J].
Marschall, Jonas ;
Carpenter, Christopher R. ;
Fowler, Susan ;
Trautner, Barbara W. .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346